These findings confirm previous data that nelfinavir does not target PI3-kinase signaling in melanoma cells (Jiang et al., 2007), and rules out an involvement of HSP90 in the inhibitory effect of nelfinavir on PAX3 protein levels. The gene discussed is PAX3; the disease is melanoma.